Survey on the impact of rheumatic and musculoskeletal diseases
Official title: EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey
Run by European Alliance of Associations in Rheumatology · NCT06461000 · Data updated 2026-11-12
This study is collecting feedback from patients with rheumatic and musculoskeletal diseases across Europe to see how these conditions affect their daily lives and healthcare experiences.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | European Alliance of Associations in Rheumatology Academic / other |
| Locations | 1 site (Kilchberg, Canton of Zurich) |
| Status | Recruiting |
| Started | June 12, 2025 |
| Main results expected | June 12, 2028 |
| Study ends | June 12, 2029 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT06461000 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older, diagnosed with at least one rheumatic or musculoskeletal disease, and residing in a EULAR country.
✕Probably not a fit
Patients who do not have access to the internet or are unable to complete online surveys may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The EULAR Impact of RMDs Survey gathers firsthand information from patients about how rheumatic and musculoskeletal diseases affect their lives across Europe. Participants complete periodic questionnaires detailing their healthcare experiences and the social and occupational impacts of their conditions. This observational study aims to create a comprehensive resource that will benefit researchers, healthcare professionals, and patients by providing insights into the burden of these diseases. The data collected will help improve care and support for individuals living with rheumatic and musculoskeletal diseases.
Why it matters
Potential benefit: If successful, this survey could lead to improved understanding and management of rheumatic and musculoskeletal diseases, enhancing patient care.
How similar studies have gone: Similar observational studies have successfully provided valuable insights into the impact of chronic diseases, suggesting this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-year-old at time of baseline survey * Living in a EULAR country at time of baseline survey * Diagnosed with at least one RMD * Valid personal e-mail address * Being able to use an internet website Exclusion Criteria: * none
Where it's running
-
Eular
Kilchberg, Canton of Zurich, Switzerland Recruiting
Study contacts
- Study coordinator: Coralie Signorell, PhD
- Email: coralie.signorell@eular.org
- Phone: 0445751564
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
-
Urdu Translation and Validation of the Nordic Musculoskeletal Questionnaire
This study tests an Urdu version of the E-NMQ to see if it reliably and accurately measures pain, stiffness, and weakness in adults with musculoskeletal conditions in Pakistan.
-
AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping
This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.
-
100-Year Human Aging and Longevity Tracking Program
This project will follow adults over their lifetimes to see if repeated health tests can predict lifespan, causes of death, serious disease, and loss of function.
-
Shoulder Health After Rehab: Home-Based Strength Training for wheelchair users
This study tests a home-based shoulder strength training program for manual wheelchair users who recently left rehabilitation to see if starting the training at 3 months versus 12 months after discharge affects shoulder health.
-
Dissolvable SakuraBead embolization for plantar fascia pain
This trial will try dissolvable SakuraBead embolization in adults with plantar fasciitis to see if it reduces heel pain better than shockwave therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.